Reply to Roussel et al
Clin Infect Dis
.
2021 Jun 1;72(11):e929.
doi: 10.1093/cid/ciaa1621.
Authors
Michael W Fried
1
,
Julie M Crawford
1
,
Andrea R Mospan
1
,
Stephanie E Watkins
1
,
Breda Munoz
1
,
Richard C Zink
1
,
Sherry Elliott
2
,
Kyle Burleson
1
,
Charles Landis
3
,
K Rajender Reddy
4
,
Robert S Brown
5
Affiliations
1
TARGET PharmaSolutions, Inc, Durham, North Carolina, USA.
2
Elliott Health Information Pros, Inc, Cary, North Carolina, USA.
3
Liver Care and Transplantation Services at University of Washington Medical Center, Seattle, Washington, USA.
4
Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
5
Department of Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine Center for Liver Disease, New York, New York, USA.
PMID:
33086377
DOI:
10.1093/cid/ciaa1621
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Letter
Comment